SCHEMBL5586912

SCHEMBL5586912

Cc1c(F)c(F)c(O)c(O)c1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LDHA P00338 6/20 0.42
LDHB P07195 6/20 0.42
DPP4 P27487 1/20 0.35
TAS1R3 Q7RTX0 3/20 0.33
TAS1R1 Q7RTX1 3/20 0.33
TAS1R2 Q8TE23 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CYP3A4 P08684 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ACHE P22303 1/20 0.33
GLRA3 O75311 1/20 0.33
GLRB P48167 1/20 0.33
ALB P02768 3/20 0.33
MAPT P10636 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374326 0.88 LDHA (0.39) LDHALDHBTAS1R3TAS1R1TAS1R2
SCHEMBL5587007 0.86 LDHA (0.42) LDHALDHBDPP4MEN1KMT2A
SCHEMBL8979014 0.84 ESR1 (0.40) LDHALDHBTAS1R3TAS1R1TAS1R2
SCHEMBL6784332 0.82 LDHA (0.38) LDHALDHBTAS1R3TAS1R1TAS1R2
SCHEMBL6578763 0.80 TAS1R3 (0.42) LDHALDHBTAS1R3TAS1R1TAS1R2
SCHEMBL2011531 0.80 MEN1 (0.46) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL10404342 0.80 LDHA (0.52) LDHALDHBDPP4CYP3A4ACHE
SCHEMBL18774734 0.80 CYP1A2 (0.41) LDHALDHBTAS1R3TAS1R1TAS1R2
SCHEMBL22279446 0.79 LDHA (0.39) LDHALDHBDPP4TAS1R3TAS1R1
SCHEMBL5588961 0.78 MEN1 (0.36) LDHALDHBDPP4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LDHA 320/4885LDHB 486/4885DPP4 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.